Introduction
Are you providing a submission as a representative of an organisation?
If yes, what is the name of your organisation?
The Walter and Eliza Hall Institute of Medical Research
Findings - Theme 1 - Technical Issues
Findings 3 to 7:
Response
The institute recognises the need to introduce clear and consistent definitions and humans should not be considered as GMOs.
Findings - Theme 2 - Regulatory Issues
Findings 8 - 15:
Response
The institute would be supportive of increasing the efficiency of the regulatory pathway involving low risk GMO dealings by permitting IBCs to vary or extend NLRDs without requirement to issue a new number. Ability to upload new or varied approved dealings directly to an OGTR database
Currently IBCs manages the annual inspection of PC1 and PC2 certified facilities. The ability for an IBC member or designated person to inspect and certify PC1 or PC2 facilities and grant interim approval, lodge the approval with the OGTR who would supply of certification stickers. The current time from lodgment to approval would assist in reducing the administrative burden on the OGTR.
We would be very supportive of using the Australian/New Zealand Standards as the guidelines for certifying facilities.
There is a need for a review of DIY biologists as they need to be include in the Scheme.
Currently IBCs manages the annual inspection of PC1 and PC2 certified facilities. The ability for an IBC member or designated person to inspect and certify PC1 or PC2 facilities and grant interim approval, lodge the approval with the OGTR who would supply of certification stickers. The current time from lodgment to approval would assist in reducing the administrative burden on the OGTR.
We would be very supportive of using the Australian/New Zealand Standards as the guidelines for certifying facilities.
There is a need for a review of DIY biologists as they need to be include in the Scheme.
Findings - Theme 3 - Governance Issues
Findings 16 - 28:
Response
The institute supports the continuation of a national consistent regulatory framework .
The institute agrees with the finding that full cost recovery would have detrimental effects on the sector in particular research organisations that need to continue to apply for funding.
The institute agrees with the finding that full cost recovery would have detrimental effects on the sector in particular research organisations that need to continue to apply for funding.
Findings - Theme 4 - Social and Ethical Issues
Findings 29 to 33:
Response
The institute would support an independent body rather than the Regulator to look at ways to improve communication with the public about gene technology in general, the Scheme, the role of the Regulator, the OGTR and how to access information leading to increase in public confidence.